Humana Inc. is facing significant financial pressure with its stock price down 41.1%, trading at $176.06, following a downgrade by Barclays from $245. Despite this, the company reports a robust annual revenue growth of around 10% and holds $4.2 billion in cash against $4.3 billion in debt. To bolster its market position, Humana is acquiring Florida-based MaxHealth to enhance its CenterWell Senior Primary Care network, while also declaring a dividend of $0.885 per share, set for payment on April 24, 2026.
“Humana Inc. · was trading at · share price · $176.06”
“HUM · had trailing P/E · P/E ratio · 19.66”
“HUM · had forward P/E · P/E ratio · 18.52”
“Humana Inc. · provides · insurance products · medical and specialty”
“HUM · trades at · normalized earnings multiple · 5.7–7.2x”
“HUM · trades at · operating cash flow multiple · 2.5x”
“Humana Inc. · delivers · annual revenue growth · approximately 10%”
“Humana Inc. · holds · cash · $4.2 billion”
“Humana Inc. · holds · debt · $4.3 billion”
“60 hedge fund portfolios · held · HUM · at the end of the third quarter”
“69 hedge fund portfolios · held · HUM · in the previous quarter”
“Humana Inc. · has a market cap of · $21.1 billion · true”
